Stock Market News

Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal

wcc wcc
Apr 27, 2026 - 03:00
0 1
Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal
To fuel its global ambitions, Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion.

Previous Article

China industrial profits jump 15.8% in March, fueled by AI and chip boom desp...

Next Article

King's visit to 'revitalise' relationship with US, says UK ambassador

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0
wcc
wcc

Related Posts

Core Scientific signs AI infrastructure deal with AMD

Core Scientific signs AI infrastructure deal with AMD

wcc
Jul 28, 2026
0
1
Hyperliquid Explains $57 Million SK Hynix Perp Liquidations After Oracle Anomaly

Hyperliquid Explains $57 Million SK Hynix Perp Liqui...

wcc
Jul 28, 2026
0
1
Brookfield sees 6.5 GW of AI data-centre capacity coming online in India

Brookfield sees 6.5 GW of AI data-centre capacity co...

wcc
Jul 28, 2026
0
1
India's June industrial output grows 7.3% y/y on manufacturing boost

India's June industrial output grows 7.3% y/y on man...

wcc
Jul 28, 2026
0
1
Should You Buy Apple Stock Before July 30?

Should You Buy Apple Stock Before July 30?

wcc
Jul 28, 2026
0
1
Germany's deep tech edge drives acceleration in VC funding

Germany's deep tech edge drives acceleration in VC f...

wcc
Jul 28, 2026
0
1

Comments (0)

User